The advantages of Emperra's ESYSTA System
Por um escritor misterioso
Descrição

Emperra New — aescuvest

Home - Esysta

Home - Esysta

Robert Bosch Venture Capital GmbH joining Emperra digital diabetes care as a new investor - Medical Design and Outsourcing
Smart Pens - A Disruptive Force in the Insulin Delivery Market

Frontiers EU-Funded Telemedicine Projects – Assessment of, and Lessons Learned From, in the Light of the SARS-CoV-2 Pandemic

Robert Bosch Venture Capital leads $3.1M round in digital diabetes startup

A Review of Emerging Technologies in Diabetes Management for Multiple-Dose Insulin-Injecting Patients With Type 2 Diabetes Who Self-monitor Blood Glucose - Malgorzata Slugocki, Damian Bialonczyk, Ayşe Elif Özdener, 2019

Bent Johnsen appointed as CEO for Emperra

Medical devices, smart drug delivery, wearables and technology for the treatment of Diabetes Mellitus - ScienceDirect

Highlights

Aescuvest International GmbH: tackling diabetes mellitus with a smart treatment management solution

PDF) Smart Connected Insulin Pens, Caps, and Attachments: A Review of the Future of Diabetes Technology

Diabetes Diary with ESYSTA

Regulating Digital Therapeutics
de
por adulto (o preço varia de acordo com o tamanho do grupo)